Journal article Open Access
ARE DMARDS BENEFICIAL IN MANAGEMENT OF PSORIASIS?
Rania Sami Iraqi
Introduction:Psoriasis is a chronic inflammatory papulosquamous skin disease with genetic predisposition and autoimmune pathogenicity. Psoriasis may also affect the joints as psoriatic arthritis and may even be associated with other conditions. Research into the pathogenesis of Psoriasis in the last few decades has given rise to several targeted therapies. Among them are Disease-modifying anti-rheumatic drugs (DMARDs), mainly used in cases of psoriatic arthritis. The article will review the various disease-modifying anti-rheumatic drugs along with strengths and weaknesses in combating Psoriasis.
The aim of work: An overview is aimed at describing various DMARDs and their use against Psoriasis.
Methodology: The review is a thorough review of PUBMED articles from the year 1984 to 2019 relating to DMARDs and Psoriasis.
Conclusion:Psoriasis is a chronic inflammatory skin disease that also affects other systems of the body due to inflammation. DMARDs are a group of drugs that are used to combat Psoriasis and various other inflammatory ailments. This review briefly discusses the most common examples of DMARDs, their mechanism of action, efficacy in trials, and adverse effects.
| Name | Size | |
|---|---|---|
|
61.Psoriasis DMARDs.pdf
md5:c0e08468284e47c597837721de11131e |
896.4 kB | Download |
| All versions | This version | |
|---|---|---|
| Views | 9 | 9 |
| Downloads | 10 | 10 |
| Data volume | 9.0 MB | 9.0 MB |
| Unique views | 9 | 9 |
| Unique downloads | 10 | 10 |
- Publication date:
- July 28, 2022
- DOI:
-
- License (for files):
- Creative Commons Attribution 4.0 International